Guillaume Froget

ZA De Glatigné, 53940 Le Genest Saint Isle
Genet, 53940, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Preclinical Pancreatic Cancer Models.

Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Preclinical Pancreatic Cancer Models.

Journal: Oncology research

Published: August 20, 2025

Evaluation of Clobetasol and Tacrolimus Treatments in an Imiquimod-Induced Psoriasis Rat Model.

Evaluation of Clobetasol and Tacrolimus Treatments in an Imiquimod-Induced Psoriasis Rat Model.

Journal: International journal of molecular sciences

Published: July 25, 2024

Whole-Cell Configuration of the Patch-Clamp Technique in the hERG Channel Assay.

Whole-Cell Configuration of the Patch-Clamp Technique in the hERG Channel Assay.

Journal: Current protocols

Published: February 09, 2024

Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models.

Evaluation of Temozolomide and Fingolimod Treatments in Glioblastoma Preclinical Models.

Journal: Cancers

Published: July 31, 2023

Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models.

Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models.

Journal: International journal of molecular sciences

Published: June 30, 2022

A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with Murine Models for Early Evaluation of Cancer Therapy and Early Drug Toxicity.

A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with Murine Models for Early Evaluation of Cancer Therapy and Early Drug Toxicity.

Journal: Cancers

Published: June 16, 2022

Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response.

Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response.

Journal: Translational oncology

Published: December 13, 2021

Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models.

Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models.

Journal: Translational oncology

Published: July 15, 2020

Overview of safety pharmacology.

Overview of safety pharmacology.

Journal: Current protocols in pharmacology

Published: February 11, 2014

An overview of QT interval assessment in safety pharmacology.

An overview of QT interval assessment in safety pharmacology.

Journal: Current protocols in pharmacology

Published: June 08, 2013

Whole-cell configuration of the patch-clamp technique in the hERG channel assay to predict the ability of a compound to prolong QT interval.

Whole-cell configuration of the patch-clamp technique in the hERG channel assay to predict the ability of a compound to prolong QT interval.

Journal: Current protocols in pharmacology

Published: June 12, 2012

The comparative sensitivity of three in vitro safety pharmacology models for the detection of lidocaine-induced cardiac effects.

The comparative sensitivity of three in vitro safety pharmacology models for the detection of lidocaine-induced cardiac effects.

Journal: Journal of pharmacological and toxicological methods

Published: March 09, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026